Literature DB >> 25399943

Vasculitis in antiphospholipid syndrome.

Lindsay Lally1, Lisa R Sammaritano2.   

Abstract

The major manifestations of antiphospholipid syndrome (APS) are caused by thrombosis within the venous or arterial vasculature, whereas the vascular lesions in systemic vasculitis result from an inflammatory infiltrate in the vessel wall. There is an association between vascular thrombosis and inflammation, however, as vasculitis can occur in APS and thromboembolic complications are seen in systemic vasculitis. Although differentiating between vasculitis and antiphospholipid-associated thrombosis can be difficult, it may be crucial to do so given the different therapeutic implications for immunosuppression or anticoagulation. This article explores the relationship between thrombosis and inflammation as it relates to APS and systemic vasculitis.

Entities:  

Keywords:  Anti-β2-glycoprotein 1 antibody; Anticardiolipin antibody; Antiphospholipid syndrome; Lupus anticoagulant; Vasculitis

Mesh:

Substances:

Year:  2015        PMID: 25399943     DOI: 10.1016/j.rdc.2014.09.009

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  11 in total

1.  Necrotising scleritis, keratitis and uveitis in primary antiphospholipid syndrome.

Authors:  Brijesh Takkar; Sudarshan Khokhar; Uma Kumar; Pradeep Venkatesh
Journal:  BMJ Case Rep       Date:  2018-05-14

Review 2.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

3.  A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia.

Authors:  Nayef M Kazzaz; Allecia M Wilson; Ruba Kado; Geoffrey D Barnes; Jason S Knight
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08       Impact factor: 4.794

4.  Longitudinally extensive transverse myelitis with anti-NMDA receptor antibodies during a systemic lupus erythematosus flare-up.

Authors:  Kentarou Takei; Mineshige Sato; Masashi Nakamura; Hiroshi Shimizu
Journal:  BMJ Case Rep       Date:  2015-11-26

Review 5.  Systemic lupus erythematosus and ocular involvement: an overview.

Authors:  Rosanna Dammacco
Journal:  Clin Exp Med       Date:  2017-12-14       Impact factor: 3.984

6.  A Very Rare Case of Mass-Like Mesenteric Fat Necrosis in a Patient with Antiphospholipid Syndrome.

Authors:  Ana Luísa Lourenço; João Lopes Dias; Joana Marques; Vera Bernardino
Journal:  GE Port J Gastroenterol       Date:  2020-06-11

7.  Visual recovery and vascular reperfusion after vaso-occlusive retinopathy from anti-phospholipid syndrome associated with systemic lupus erythematosus.

Authors:  Jordan D Deaner; Andrew S Zeft; Parisa Emami-Naeini; Careen Y Lowder
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-02

8.  Efficacy of Rituximab for Refractory Pyoderma Gangrenosum-Like Ulcers in Granulomatosis With Polyangiitis Associated to Antiphospholipid Antibodies.

Authors:  Julia Riera; Jorge Musuruana; Cecilia Costa; Javier Cavallasca
Journal:  Arch Rheumatol       Date:  2020-01-08       Impact factor: 1.472

Review 9.  Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome.

Authors:  Marko Radic; Debendra Pattanaik
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

10.  Severe vaso-occlusive lupus retinopathy in the early stage of a pediatric patient with systemic lupus erythematosus: a case report.

Authors:  Guoping Huang; Huijun Shen; Jingli Zhao; Jianhua Mao
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.